Humana Profits Decline Amid Lower 2026 Medicare Advantage Star Ratings

Key Facts

1Humana's stock has slumped this year, fluctuating on news regarding government payment plans for Medicare Advantage insurers.

Humana reported lower first-quarter profits compared to last year, yet the results significantly outperformed market expectations. The company posted adjusted EPS of $10.31 on revenue of $39.65 billion, both exceeding analyst estimates. A key driver was the benefit ratio of 89.4%, which was bolstered by lower-than-anticipated medical costs during the period. Despite these strong quarterly figures, the insurer continues to navigate headwinds from lower 2026 Medicare Advantage Star Ratings, which threaten future federal bonus payments. Investors are weighing the current earnings beat against long-term regulatory challenges and reimbursement shifts. This performance highlights Humana's operational efficiency amid a complex and evolving healthcare landscape.

6 months ago

Version History

2 additional sources confirmed this story

Version 56 months ago

What changed: Added new data regarding Alignment Healthcare's return to profitability due to lower medical costs, providing a benchmark for CVS Health's performance.

Version 46 months ago

What changed: Shifted focus from Humana's realized earnings to CVS Health's upcoming Q1 earnings expectations and segment performance drivers.

Version 36 months ago

What changed: Updated the story to include the earnings and revenue beat, specifically mentioning the $10.31 EPS and the 89.4% benefit ratio driven by lower medical costs.

Version 26 months ago

What changed: The story was updated to reflect a decline in first-quarter profits due to lower 2026 Medicare Advantage Star Ratings, shifting from the previous narrative of an earnings beat.

Version 16 months ago

What changed: Updated the story from an earnings preview to a confirmed earnings beat driven by lower medical expenses.